Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NuvaRing vs OrthoEvra in women switching from oral contraceptives
NCT00269620Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Jun 2005
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of etonogestrel + ethinyl estradiol in contraception, sponsored by University of Pittsburgh. Primary endpoint: Continuation into the fourth cycle at 4 months. Started Jun 2005; status: completed.
02
Drugs
etonogestrel + ethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00269620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00269620.